TickerSutra

NSE: ARIES · BSE: 532935 · ISIN INE298I01015

Aries Agro Limited stock analysis

Aries Agro Limited ranks #545 in the TickerSutra evidence-ranked universe with a score of 63/100 and 95% data confidence. The latest captured fundamentals show ROCE of 21.2%, quarterly sales growth of 16.4% and quarterly profit growth of 48.6%.
Complete evidence gate pass governance reviewUpdated 29 Sept 2026
TICKERSUTRA SCORE63/100

Monitor only

#545 of 5,430 ranked equities
Market capitalisation₹625.14cr
ROCE21.2%
Quarterly sales growth16.4%
Quarterly profit growth48.6%
P/E ratio13.1×
Promoter pledge0.0%

INVESTMENT EVIDENCE

What supports—and challenges—the thesis

Evidence in favour

  • ROCE is 21.2%
  • Low debt/equity of 0.17×
  • Strong CFO/EBITDA of 0.97×
  • 16.8% three-year sales CAGR
  • CWIP indicates an active capacity pipeline
  • No promoter shares are reported as pledged

Risks and constraints

  • No calculated threshold risk in the current snapshot.

Still unresolved: Related-party exposure · Broad media sentiment

FINANCIAL TRAJECTORY

Recent operating history

PeriodRevenueOperating profitNet profitOperating margin
2022₹432cr₹47cr₹12cr11.0%
2023₹472cr₹48cr₹16cr10.0%
2024₹516cr₹55cr₹18cr11.0%
2025₹622cr₹68cr₹33cr11.0%
2026₹753cr₹89cr₹42cr12.0%
TTM₹779cr₹94cr₹47cr12.0%
Debt / equity0.17×
CFO / EBITDA0.97×
Operating margin12.0%
Free cash flow₹38cr
Sales CAGR · 3Y16.8%
Profit CAGR · 3Y37.9%

EXCHANGE EVENT TRIGGERS

Latest corporate disclosures

0 positive catalysts0 negative catalysts4 routine filings

MANAGEMENT COMMENTARY

Signals from filed documents

Operating leverageHigh severity · 1 mention
Positive catalyst

The conversion of these bookings, along with routine order inflows, resulted in total revenue of ₹917.64 crores for FY 2025–26, reflecting a growth of 17.87% over the previous financial year. This robust top-line performance, supported by improved product mix, operating leverage, and cost optimization initiatives, contributed to a strengthening of margins and a commensurate improvement in profitability during the yea

Backward integrationHigh severity · 4 mentions
Positive catalyst

Outlook FY 2026–27 marks the 57 th year of Aries’ operations and is expected to remain challenging amid geopolitical uncertainties, potential El Niño conditions, China’s fertilizer export restrictions, subdued farm-gate prices and the projected 94% monsoon relative to LPA. The Company remains prepared to navigate demand and supply volatility through advance inventory planning, automation, backward integration and inc

Raw material inflationHigh severity · 2 mentions
Risk easing

Amarak Chemicals FZC, UAE has produced 3,613 MT of Sulphur Bentonite and other value added Sulphur products for sale in India and globally. HIGHLIGHTS & KEY DEVELOPMENTS Highlights: Financial Year 2025–26 was marked by external headwinds, including geopolitical tensions leading to intermittent fuel supply constraints, elevated logistics and raw material costs; notwithstanding these challenges, the Company successfull

Market share gainHigh severity · 1 mention
Positive catalyst

Titled “Freedom to Create, Courage to Lead”. Awarded ‘Company of the Year’ and acclaimed as ‘Super brand’ by Snail Integral, reaffirming its strong brand equity, market leadership, and trusted reputation in the agri-input industry. The Group Head- Business Development (India), Mr.

Niche productsHigh severity · 1 mention
Positive catalyst

30th November 2025 - The Company commissioned a new, expanded, and automated depot at Vijayawada, further strengthening its distribution network in South India. The Vijayawada facility also received the Plantomycin manufacturing licence, marking an important milestone in the Company’s specialized product portfolio. 17th January 2026 – Our Associate Company, M/s.

Product approvalsHigh severity · 3 mentions
Positive catalyst

InAgritech, Indonesia (July 2025) – Conducted meetings with potential customers from Indonesia and other South Asian markets, exploring business opportunities. Sahara Expo, Egypt (September 2025) – Established connections with leading Egyptian companies and initiated product registration processes with several partners. Growtech, Turkey (November 2025) – Engaged with local companies; noted that the Turkish market fol

Export market updatesModerate severity · 5 mentions
Constructive

Benefits derived: • Improved manufacturing efficiency and cost optimization • Enhanced product quality and customer satisfaction • Strengthened operational excellence through continuous improvement practices The Company has not imported any technology during the year under review. Foreign Exchange Earnings and Outgo The Company continues to expand its global footprint through strategic initiatives aimed at increasing

Regulatory updatesModerate severity · 21 mentions
Constructive

· Reduction in production costs and enhanced environmental compliance. · Strengthened regulatory compliance and development of sustainable farming solutions. · Increased market penetration through innovative and customized offerings.

Regulatory approvalLow severity · 25 mentions
Watch

There is one observation in the Report as “Related Party Transactions with the Overseas Subsidiary, Golden Harvest Middle East, FZC, UAE exceeded the Audit Committee Approved limit by Rs. 1.79 Crore during the Quarter ended December 31, 2025 due to business exigencies which was Ratified/Approved by the Audit Committee at their Meeting held on 13th February, 2026. Management Explanations The said limit was exceeded in

Institutional interestLow severity · 4 mentions
Watch

Further, the Share Holders are also requested to note that in case their PAN is not linked with Aadhaar the same is shown on the Income Tax site as ‘INOPERATIVE PAN”, in such cases also the tax will be deducted at a higher rate of 20%. Non-resident shareholders [including Foreign Institutional Investors (FIIs) / Foreign Portfolio Investors(FPIs)] can avail beneficial rates under tax treaty between India and their cou

HOW TO READ THIS PAGE

Evidence, freshness and limitations

What does the TickerSutra score mean?

The score ranks captured evidence across financial quality, growth, moat and margins, regulatory catalysts, governance, institutional trend and valuation comfort. It is a research-prioritization tool—not a buy recommendation or price target.

Which sources support this page?

Financial history, ownership and pledge data, NSE and BSE filings, annual reports and available earnings-call transcripts are combined here. Use the source trail and original exchange document before relying on a decision-critical fact.

Why can an item be unresolved?

Unresolved means the current captured source window did not provide enough evidence for that check. It does not establish that a risk or relationship is absent.

Maintained by TickerSutra Research · Snapshot updated 29 Sept 2026 · Read the methodology · Read the disclaimer

DIRECTOR & BUSINESS NETWORK

Loading corporate intelligence

Loading universe coverage and exchange-backed evidence…